![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/17/2899470/0/en/Zymeworks-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-ZW171-a-novel-2-1-T-cell-Targeting-Bispecific-Antibody-for-Mesothelin-expressing-Cancers.html
https://www.globenewswire.com/news-release/2024/06/10/2895828/0/en/Zymeworks-Announces-China-NMPA-Acceptance-of-Biologics-License-Application-for-Zanidatamab-for-Second-Line-Treatment-of-Biliary-Tract-Cancer.html
https://www.globenewswire.com/news-release/2024/05/28/2888842/0/en/Zymeworks-Announces-Participation-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/02/2874710/0/en/Zymeworks-Provides-Corporate-Update-and-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/30/2871982/0/en/Zymeworks-Announces-Participation-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/04/11/2861315/0/en/Zymeworks-To-Report-First-Quarter-2024-Financial-Results-and-Host-Conference-Call-on-May-2-2024.html
https://www.globenewswire.com/news-release/2024/04/08/2859000/0/en/Zymeworks-Presents-New-Data-from-Multiple-Preclinical-Development-Programs-at-2024-American-Association-for-Cancer-Research-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/28/2853788/0/en/Zymeworks-Announces-Appointment-of-Dr-Neil-Gallagher-to-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/03/27/2852976/0/en/Zymeworks-Announces-Participation-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/03/06/2841783/0/en/Zymeworks-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html